Press "Enter" to skip to content

Patent delisted for Acorda drug AMPYRA

1
Copyright © DrugPatentWatch. Originally published at Patent delisted for Acorda drug AMPYRA

Annual Drug Patent Expirations for AMPYRA
Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers.

Drug patent litigation for AMPYRA.

The generic ingredient in AMPYRA is dalfampridine. Two suppliers are listed for this compound. Additional details are available on the dalfampridine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Patent delisted for Acorda drug AMPYRA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!